Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial

References

• Prentice MB, Rahalison L. Plague. Lancet 2007; 369:1196-207; PMID:17416264; http://dx.doi.org/10.1016/S0140-6736(07)60566-2
   PubMed Web of Science ®Google Scholar
• Cobbs CG, Chansolme DH. Plague. Dermatologic clinics 2004; 22:303-12; PMID:15207311; http://dx.doi.org/10.1016/j.det.2004.03.007
   PubMed Web of Science ®Google Scholar
• pestisQuenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O. Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun 2008; 76:2025-36; PMID:18347051; http://dx.doi.org/10.1128/IAI.00105-08
   PubMed Web of Science ®Google Scholar
• Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Jama 2000; 283:2281-90; PMID:10807389; http://dx.doi.org/10.1001/jama.283.17.2281
   PubMed Web of Science ®Google Scholar
• Zilinskas RA. The anti-plague system and the Soviet biological warfare program. Crit Rev Microbiol 2006; 32:47-64; PMID:16610337; http://dx.doi.org/10.1080/10408410500496896
   PubMed Web of Science ®Google Scholar
• Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323:299-315; PMID:12074485; http://dx.doi.org/10.1097/00000441-200206000-00003
   PubMed Web of Science ®Google Scholar
• Anisimov AP, Lindler LE, Pier GB. Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev 2004; 17:434-64; PMID:15084509; http://dx.doi.org/10.1128/CMR.17.2.434-464.2004
   PubMed Web of Science ®Google Scholar
• Stenseth NC, Atshabar BB, Begon M, Belmain SR, Bertherat E, Carniel E, Gage KL, Leirs H, Rahalison L. Plague: past, present, and future. PLoS Med 2008; 5:e3; PMID:18198939; http://dx.doi.org/10.1371/journal.pmed.0050003
   PubMed Web of Science ®Google Scholar
• Human plague: review of regional morbidity and mortality, 2004-2009. Wkly Epidemiol Rec 2009; 85:40-5; PMID:20151494
   PubMedGoogle Scholar
• Bevins SN, Baroch JA, Nolte DL, Zhang M, He H. Yersinia pestis: examining wildlife plague surveillance in China and the USA. Integrative zoology 2012; 7:99-109; PMID:22405453; http://dx.doi.org/10.1111/j.1749-4877.2011.00277.x
   PubMed Web of Science ®Google Scholar
• Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000; 355:111-3; PMID:10675169; http://dx.doi.org/10.1016/S0140-6736(99)05163-6
   PubMed Web of Science ®Google Scholar
• Jones RT, Borchert J, Eisen R, MacMillan K, Boegler K, Gage KL. Flea-Associated Bacterial Communities across an Environmental Transect in a Plague-Endemic Region of Uganda. PloS one 2015; 10:e0141057; PMID:26485147; http://dx.doi.org/10.1371/journal.pone.0141057
   PubMedGoogle Scholar
• Butler T. Plague gives surprises in the first decade of the 21st century in the United States and worldwide. Am J Trop Med Hyg 2013; 89:788-93; PMID:24043686; http://dx.doi.org/10.4269/ajtmh.13-0191
   PubMed Web of Science ®Google Scholar
• Feodorova VA, Corbel MJ. Prospects for new plague vaccines. Exp Rev Vaccin 2009; 8:1721-38; PMID:19943765; http://dx.doi.org/10.1586/erv.09.129
   PubMed Web of Science ®Google Scholar
• Anderson GW, Jr., Heath DG, Bolt CR, Welkos SL, Friedlander AM. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am J Trop Med Hyg 1998; 58:793-9; PMID:9660466
   PubMed Web of Science ®Google Scholar
• Heath DG, Anderson GW, Jr., Mauro JM, Welkos SL, Andrews GP, Adamovicz J, et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 1998; 16:1131-7; PMID:9682370; http://dx.doi.org/10.1016/S0264-410X(98)80110-2
   PubMed Web of Science ®Google Scholar
• Williamson ED, Eley SM, Griffin KF, Green M, Russell P, Leary SE, Oyston PC, Easterbrook T, Reddin KM, Robinson A. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 1995; 12:223-30; PMID:8745007; http://dx.doi.org/10.1111/j.1574-695X.1995.tb00196.x
   PubMed Web of Science ®Google Scholar
• Williams RC, Jr., Gewurz H, Quie PG. Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J Infect Dis 1972; 126:235-41; PMID:4559742; http://dx.doi.org/10.1093/infdis/126.3.235
   PubMed Web of Science ®Google Scholar
• Straley SC, Skrzypek E, Plano GV, Bliska JB. Yops of Yersinia spp. pathogenic for humans. Infect Immun 1993; 61:3105-10; PMID:8335339
   PubMed Web of Science ®Google Scholar
• Anisimov AP, Dentovskaya SV, Panfertsev EA, Svetoch TE, Kopylov P, Segelke BW, Zemla A, Telepnev MV, Motin VL. Amino acid and structural variability of Yersinia pestis LcrV protein. Infect Genet Evolution 2010; 10:137-45; PMID:19835996; http://dx.doi.org/10.1016/j.meegid.2009.10.003
   PubMed Web of Science ®Google Scholar
• Jefferson T, Demicheli V, Pratt M. Vaccines for preventing plague. Cochrane Database Syst Rev 2000; 2:CD000976; PMID:10796565
   PubMedGoogle Scholar
• Williamson ED, Flick-Smith HC, Lebutt C, Rowland CA, Jones SM, Waters EL, Gwyther RJ, Miller J, Packer PJ, Irving M. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 2005; 73:3598-608; PMID:15908389; http://dx.doi.org/10.1128/IAI.73.6.3598-3608.2005
   PubMed Web of Science ®Google Scholar
• Williamson ED, Oyston PC. Protecting against plague: towards a next-generation vaccine. Clin Exp Immunol 2013; 172:1-8; PMID:23480179; http://dx.doi.org/10.1111/cei.12044
   PubMed Web of Science ®Google Scholar
• Roggenkamp A, Geiger AM, Leitritz L, Kessler A, Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 1997; 65:446-51; PMID:9009295
   PubMed Web of Science ®Google Scholar
• Ranjbar R, Afshar D. Development of a loop-mediated isothermal amplification assay for rapid detection of Yersinia enterocolitica via targeting a conserved locus. Iran J Microbiol 2015; 7:185-90; PMID:26697156
   PubMedGoogle Scholar
• Tomaso H, Mooseder G, Al Dahouk S, Bartling C, Scholz HC, Strauss R, Treu TM, Neubauer H. Seroprevalence of anti-Yersinia antibodies in healthy Austrians. Eur J Epidemiol 2006; 21:77-81; PMID:16450210; http://dx.doi.org/10.1007/s10654-005-5047-z
   PubMed Web of Science ®Google Scholar
• Runfola JK, House J, Miller L, Colton L, Hite D, Hawley A, Mead P, Schriefer M, Petersen J, Casaceli C, et al. Outbreak of Human Pneumonic Plague with Dog-to-Human and Possible Human-to-Human Transmission–Colorado, June-July 2014. MMWR Morb Mortal Wkly Rep 2015; 64:429-34; PMID:25928467
   PubMed Web of Science ®Google Scholar
• Cui Y, Yang X, Xiao X, Anisimov AP, Li D, Yan Y, Zhou D, Rajerison M, Carniel E, Achtman M, et al. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infect Genet Evolution 2014; 26:172-9; PMID:24905600; http://dx.doi.org/10.1016/j.meegid.2014.05.023
   PubMed Web of Science ®Google Scholar